Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Depotech(depo) -- Ignore unavailable to you. Want to Upgrade?

To: ForYourEyesOnly who wrote (238)	11/21/1997 8:18:00 AM
From: Tom D	Read Replies (1) \| Respond to of 887

Is DEPO presenting at the BankAmerica Robertson Stephens Medical conference next month? I haven't been able to get a list of presenting companies. Would appreciate the info in regards to DEPO. Tom D

To: ForYourEyesOnly who wrote (238)	11/21/1997 9:41:00 AM
From: chirodoc	Read Replies (2) \| Respond to of 887

<<<<<<If this cancer drug is approved, I can't imagine that the BIG BOYS will settle for nibbling in 1000 share chunks ..........there is no question that you are right. that is why these things spike so wildly on approval. there may be some small selling on the 17th and 18th as the momentum guys get their 1-2 points. but the big pop will probably happen in the couple days after approval--quite a few analysts are watching. .........they will see this as a lay-up--it will be profitable because there is already demand for the chemistry. and, as you have seen, the fact that there is no international exposure makes this one of the SAFER sectors--the street is bidding up pharmas, and watching bios carefully. .......can you imagine biotech being safe? what a concept!